[
  {
    "ts": null,
    "headline": "Veeva Systems, IQVIA Dispute Resolution Removes Investor Concerns Around CRM Data Risk, Oppenheimer Says",
    "summary": "Veeva Systems' (VEEV) dispute resolution with IQVIA (IQV) removes investor concerns about the risk o",
    "url": "https://finnhub.io/api/news?id=81c9b4dc3c3f8c535db5b8339b30c621a57e90bbfbd6c263e3023580f36c183b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755614989,
      "headline": "Veeva Systems, IQVIA Dispute Resolution Removes Investor Concerns Around CRM Data Risk, Oppenheimer Says",
      "id": 136430573,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Veeva Systems' (VEEV) dispute resolution with IQVIA (IQV) removes investor concerns about the risk o",
      "url": "https://finnhub.io/api/news?id=81c9b4dc3c3f8c535db5b8339b30c621a57e90bbfbd6c263e3023580f36c183b"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Global Value Fund Q2 2025 Commentary",
    "summary": "Artisan Global Value Fund Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=4de19b34dbe280dc6329055127dce2e9120c176d98bcaf89d03aa5de51196f3c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755599400,
      "headline": "Artisan Global Value Fund Q2 2025 Commentary",
      "id": 136418718,
      "image": "",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4de19b34dbe280dc6329055127dce2e9120c176d98bcaf89d03aa5de51196f3c"
    }
  },
  {
    "ts": null,
    "headline": "Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how drug development inputs & services stocks fared in Q2, starting with IQVIA (NYSE:IQV).",
    "url": "https://finnhub.io/api/news?id=f0f511fea6198991eabaaa18ff052b88ae849609203265150c177bdc4ab524ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755574312,
      "headline": "Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks",
      "id": 136430574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how drug development inputs & services stocks fared in Q2, starting with IQVIA (NYSE:IQV).",
      "url": "https://finnhub.io/api/news?id=f0f511fea6198991eabaaa18ff052b88ae849609203265150c177bdc4ab524ad"
    }
  }
]